Medivation, Inc.: Mystery Medicine for Alzheimer's May Yield Advance for Pfizer Inc.

Bookmark and Share

Bloomberg -- Doctors may learn next month that Dimebon, a 27-year-old hay fever treatment and one of the most mysterious compounds yet tried to fight dementia, is poised to become their newest and perhaps best weapon against Alzheimer’s.

Back to news